#bgtd

[belfry-ghost]

WIP game

Rules: You will be given a word. Share one sentence/excerpt from your wip(s) that start with each letter of that word.

From @clockwayswrites with "FROG"

F : Brotherdoption AU

Fondness and familiarity are the only reason he spots something amiss at the peak of his swing—a flash of white on a gargoyle in the otherwise dark landscape of Gotham’s rooftops. He changes directions without really thinking, following his instincts like he always has. It’s gotten him into plenty of trouble in his life, following hunches and gut feelings over the cold logic and hard facts Bruce favors, but it’s also gotten him out of plenty of trouble.  And, well. No Bat worth their cape can keep their muzzle out of trouble when it comes knocking. 

R : Batgirl!Tim Drake AU

“Robin.”  Cassie nearly screams. First Batgirl, then Robin, and now Batman himself. She doesn’t understand what it is about Gotham that seems to generate scary, sneaky heroes. She’s starting to think they get a kick out of scaring poor, unsuspecting teammates.

O : Cousin Sam AU

“Oh my god,” Sam says as things begin falling into place. “Tim.”  Ohhhhh nooo. She can already hear the sound of Tucker and Val laughing at her. Fuck, she thought he was out—starting fires in alleys, or underage drinking or destroying public property or whatever normal teenagers did. Oh, Christ. Her baby cousin was a vigilante. This had to be some kind of karma.

G : Three of a Kind [Mentor!Vlad + Halfa!Jason AU]

Gotham appeals to him for a variety of reasons—the looming, eponymously gothic architecture, the thin atmosphere of ectoplasm, the way the shadows themselves seem alive, crawling and writhing like eels in a pond. 

thank you for the tag clock <333

tagging uh, @phantomfen, @em-is-doing-something, @lokiitama if y'all wanna :3 sorry if you've already been tagged lol--

Word: DARK

[annahcherryfujoshi]

Bagutodo my new religião 🛐💜

[tsuncoon]

[blarrrgghy]

here’s a headcanon for you guys:

uuuuuh blinky loves and appreciates AAARRRGGH so much

[kiwibirdlafayette]

♪ Take me back, take me back to the beginning to the days of adventure and love~ take me back, and let me pause at intermission for the nights of your stories and lore; and fireflies on the roof ♪

I started writing some lines for the Trollhunters musical and?? i had come up with these lyrics about two years ago and it kinda matched?? sorta?? the song fireflies on the roof is meant to be like reminiscent of times past that the character wishes would return it seemed like it would make a sweet interlude for the musical and I love doing this chalky style which i think is trademark of the musical now haha

[arthurshuge-tractsofland]

Hi scrunklies :3

This is Kiwibirdlafayette, im not getting back into the ToA fandom but I occasionally do enjoy posting about these losers /affectionate and I’ve decided to make a different place for it since I’ve moved on to other stuff on main :D

I was in the fandom back when the show first came out; you might remember the Trollhunters Roleswap, or the Multiple Amulet AU (and some other random shenanigans) as well as my countless Wizards theories (none of which ended up coming true LMAO)-

- but I mostly like troll dads/BGTD/Blinky and Aaarrrgghh as canon husbands! :D

Anyway yeah. also toa!Arthur’s tits are nuts

AU/Fanon Masterpost

[urbanbetty]

We're here at the @michaelcolebgtd class today! Learning all the things. #bgtd 💵💰 (at City Lights Georgetown)

[atomicjellyfishdelusion]

Antibodies Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players 2028

Increasing adoption of therapeutic antibodies along with elevated rate of product approval in developing countries is propelling the growth of the global antibodies market. The market had surpassed US$ XX Bn in 2017. Additionally, approval of monoclonal antibody products, combined with drug conjugates, antibody fragments, and therapeutic antibodies in key markets of Europe, Japan and the U.S. have boosted the growth of the market as well as inexpensive biosimilar antibody therapeutics available in the market is another driving factor for the market.

However, failure of investigational drugs in late stages of improvement and side effects associated with antibody treatment can be key factors to pose challenge to widespread adoption. Antibodies administration has been linked with acute anaphylaxis and serum sickness, restraining the growth of the market. The global antibodies market is anticipated to expand at CAGR over the forecast period, witnessing to surpass US$ XX Bn in terms of revenue 2026.

Access insightful study with over 100+ pages, list of tables & figures, profiling 10+ companies. Ask for Sample Copy@ https://www.trendsmarketresearch.com/report/sample/3735

Segmental Analysis of Antibodies Market

Monoclonal antibodies segment, by drug type had robust demand in 2017 and secured above 93% market share in terms of revenue. This segment had generated nearly US$ XX Bn. Antibody drugs complexes and polyclonal antibodies are likely to exhibit minority market share.

Hospitals are likely to remain the largest end-user in the market and accounted for more than 85% market share in terms of revenues in 2017. The hospital end-user segment had exhibited y-o-y growth rate of nearly 13% and surpassed XX Bn in revenues.

The global antibodies market has been segmented on the basis of disease indication into autoimmune disorders, CNS disorders, cancer and cardiovascular diseases. Cancer was the most leading indication segment, which had accounted for nearly 55% market share in terms of revenues in 2017. In revenues, cardiovascular disease segment was the smallest segment in the antibodies market and had witnessed the lowest growth rate amongst other indication segments.

U.S. to Hold Majority Share of North America Antibodies Market

North America was the largest market for antibodies and had accounted for nearly two-fourth of the revenue share of the global antibodies market in 2016. Therapeutics antibody products are likely to witness submission of biologics licence application (BLA) in the U.S., whereas in Biologics and Genetic Therapies Directorate (BGTD) oversees the biological product’s approval. The U.S. is likely to hold majority share of the North America antibodies market in terms of revenues with highest growth rate than Canada.

Checkout Inquiries to Purchase or Customize the Market @ https://www.trendsmarketresearch.com/checkout/3735/Single

                        Additionally, APEJ and Western Europe are likely to be the other top antibodies markets. While markets in Germany, France and the U.K. are likely to continue their top position in Western Europe, in APEJ, demand for antibodies is likely to remain largely concentrated in India, ASEAN and China.

Grab Your Report at an Impressive Discount! Please click here @ https://www.trendsmarketresearch.com/report/discount/3735

Johnson & Johnson, AbbVie Inc., and F. Hoffmann-La Roche AG will continue their position as top 3 players in the global antibodies market. In revenues, these three players collectively generate nearly 56% market share. Remicade (J&J), Avastin (Roche), Herceptin, and Humira (AbbVie) are successful drugs in the market. Novartis, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, and Merck & Co are some other leading players operating in the global antibodies market. Strengthening collaboration with distribution partners and achieving product approval from FDA and EU are key strategy for prominent players in the market.

[tanadoloutlet]

Boboli Authentic Original Overrun Stocks Size 3-8 MOQ 10 Price 6$/pc 😀Finding my full catalog in instagram @tanadolbkk 👉Or follow my page Http://www.Facebook.com/tanadoloutlet 🙏Directly order and info@tanadol.com 🧮WhatsApp📣+66949424526#wholesale Bangkok #wholesale clothing #made in Thailand #authentic#wholesale kids fashion #original overrun stocks #originalkidsbrandname#originalbrand#wholesaleBaby#customkidsclothes#girlclothes #must have#rare item#kidsfashion #kidstyle #tanadoloutlet #tanadolBangkok #onlineOnly#thailandwholesale #tanadolthailand #tanadolwholesale #childrenswear #childrenfashion #childrencloset #childrenclothes #childrenclosetthailand https://www.instagram.com/p/BvA-fy-BGtD/?utm_source=ig_tumblr_share&igshid=9babq8or7ivr

[spacetell]

W bgtd

TERNYATA PERASAANKU PADAMU, BYASA BYASA SAJAAA 🎶🎤

[marketresearchandconsultant-blog]

Antibodies Market Poised to Garner Maximum Revenues During 2026

Increasing adoption of therapeutic antibodies along with elevated rate of product approval in developing countries is propelling the growth of the global antibodies market. The market had surpassed US$ 104 Bn in 2016. Additionally, approval of monoclonal antibody products, combined with drug conjugates, antibody fragments, and therapeutic antibodies in key markets of Europe, Japan and the U.S. have boosted the growth of the market as well as inexpensive biosimilar antibody therapeutics available in the market is another driving factor for the market.

 Request for a sample of report @

https://mindaspiremarketresearch.com/request-sample/report/antibodies-market-global-industry-analysis-size-sales-and-forecast-by-2026

 However, failure of investigational drugs in late stages of improvement and side effects associated with antibody treatment can be key factors to pose challenge to widespread adoption. Antibodies administration has been linked with acute anaphylaxis and serum sickness, restraining the growth of the market. The global antibodies market is anticipated to expand at CAGR over the forecast period, witnessing to surpass US$ 340 Bn in terms of revenue 2026.

 Segmental Analysis of Antibodies Market

 Monoclonal antibodies segment, by drug type had robust demand in 2016 and secured above 93% market share in terms of revenue. This segment had generated nearly US$ 100 Bn. Antibody drugs complexes and polyclonal antibodies are likely to exhibit minority market share.

 Hospitals are likely to remain the largest end-user in the market and accounted for more than 85% market share in terms of revenues in 2016. The hospital end-user segment had exhibited y-o-y growth rate of nearly 13% and surpassed US$ 89 Bn in revenues.

 The global antibodies market has been segmented on the basis of disease indication into autoimmune disorders, CNS disorders, cancer and cardiovascular diseases. Cancer was the most leading indication segment, which had accounted for nearly 55% market share in terms of revenues in 2016. In revenues, cardiovascular disease segment was the smallest segment in the antibodies market and had witnessed the lowest growth rate amongst other indication segments.

 U.S. to Hold Majority Share of North America Antibodies Market

 North America was the largest market for antibodies and had accounted for nearly two-fourth of the revenue share of the global antibodies market in 2016. Therapeutics antibody products are likely to witness submission of biologics licence application (BLA) in the U.S., whereas in Biologics and Genetic Therapies Directorate (BGTD) oversees the biological product’s approval. The U.S. is likely to hold majority share of the North America antibodies market in terms of revenues with highest growth rate than Canada.

 Additionally, APEJ and Western Europe are likely to be the other top antibodies markets. While markets in Germany, France and the U.K. are likely to continue their top position in Western Europe, in APEJ, demand for antibodies is likely to remain largely concentrated in India, ASEAN and China.

��Ask an Analyst @

https://mindaspiremarketresearch.com/inquire/report/antibodies-market-global-industry-analysis-size-sales-and-forecast-by-2026

  Johnson & Johnson, AbbVie Inc., and F. Hoffmann-La Roche AG will continue their position as top 3 players in the global antibodies market. In revenues, these three players collectively generate nearly 56% market share. Remicade (J&J), Avastin (Roche), Herceptin, and Humira (AbbVie) are successful drugs in the market. Novartis, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, and Merck & Co are some other leading players operating in the global antibodies market. Strengthening collaboration with distribution partners and achieving product approval from FDA and EU are key strategy for prominent players in the market.

[vikasbahurupi1-blog]

Increasing Consumer Awareness to Fuel Adoption of Antibodies Market

Increasing adoption of therapeutic antibodies along with elevated rate of product approval in developing countries is propelling the growth of the global antibodies market. The market had surpassed US$ 104 Bn in 2016. Additionally, approval of monoclonal antibody products, combined with drug conjugates, antibody fragments, and therapeutic antibodies in key markets of Europe, Japan and the U.S. have boosted the growth of the market as well as inexpensive biosimilar antibody therapeutics available in the market is another driving factor for the market.

However, failure of investigational drugs in late stages of improvement and side effects associated with antibody treatment can be key factors to pose challenge to widespread adoption. Antibodies administration has been linked with acute anaphylaxis and serum sickness, restraining the growth of the market. The global antibodies market is anticipated to expand at CAGR over the forecast period, witnessing to surpass US$ 340 Bn in terms of revenue 2026.

Request For Report Sample with Table of Contents@ https://www.researchreportinsights.com/report/sample/110114965/Antibodies-Market 

Segmental Analysis of Antibodies Market

Monoclonal antibodies segment, by drug type had robust demand in 2016 and secured above 93% market share in terms of revenue. This segment had generated nearly US$ 100 Bn. Antibody drugs complexes and polyclonal antibodies are likely to exhibit minority market share.

Hospitals are likely to remain the largest end-user in the market and accounted for more than 85% market share in terms of revenues in 2016. The hospital end-user segment had exhibited y-o-y growth rate of nearly 13% and surpassed US$ 89 Bn in revenues.

The global antibodies market has been segmented on the basis of disease indication into autoimmune disorders, CNS disorders, cancer and cardiovascular diseases. Cancer was the most leading indication segment, which had accounted for nearly 55% market share in terms of revenues in 2016. In revenues, cardiovascular disease segment was the smallest segment in the antibodies market and had witnessed the lowest growth rate amongst other indication segments.

Request For Report Discount@ https://www.researchreportinsights.com/report/discount/110114965/Antibodies-Market 

U.S. to Hold Majority Share of North America Antibodies Market

North America was the largest market for antibodies and had accounted for nearly two-fourth of the revenue share of the global antibodies market in 2016. Therapeutics antibody products are likely to witness submission of biologics licence application (BLA) in the U.S., whereas in Biologics and Genetic Therapies Directorate (BGTD) oversees the biological product’s approval. The U.S. is likely to hold majority share of the North America antibodies market in terms of revenues with highest growth rate than Canada.

Additionally, APEJ and Western Europe are likely to be the other top antibodies markets. While markets in Germany, France and the U.K. are likely to continue their top position in Western Europe, in APEJ, demand for antibodies is likely to remain largely concentrated in India, ASEAN and China.

Johnson & Johnson, AbbVie Inc., and F. Hoffmann-La Roche AG will continue their position as top 3 players in the global antibodies market. In revenues, these three players collectively generate nearly 56% market share. Remicade (J&J), Avastin (Roche), Herceptin, and Humira (AbbVie) are successful drugs in the market. Novartis, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, and Merck & Co are some other leading players operating in the global antibodies market. Strengthening collaboration with distribution partners and achieving product approval from FDA and EU are key strategy for prominent players in the market.

Report Analysis@ https://www.researchreportinsights.com/report/rd/110114965/Antibodies-Market 

[tsuncoon]

Arrrgh: How did you know I was going to propose?

Blinky: Toby hasn’t been able to look at me without crying all month.

[blarrrgghy]

blinky and aarrrgghh is a big thing. Apparently dicky and gunmar is too.

I suppose the Galadrigals like their mates to be BGTDs. 

[kiwibirdlafayette]

roleswap au blinky can read fluent troll and reads love stories from troll books to aaarrrgghh but he cant understand half of it but it still sounds really pretty to him

[texasfirewalkers-blog]

@danceacrosstexasatx packed...#BGTD: #djpeewee